This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jason Brandt, PhD; Kimberly A. Quaid, PhD; Susan E. Folstein, MD
The Johns Hopkins Medical Institutions Baltimore, Md

JAMA. 1989;262(17):2385.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply. —

We thank Quarrell et al for highlighting some of the social issues raised by presymptomatic diagnosis of disease with molecular genetic tests. As clinicians and researchers testing for Huntington's disease, we are concerned that those found to be at increased risk for this illness not be subject to unreasonable discrimination. While Quarrell et al admonish us to be realistic about the needs of the insurance industry, our central concern will always be for the health and well-being of those who seek our counsel, technical expertise, and care.

We are very aware that the insurance industry is based on the concept of differential risk. Those who have poor driving records pay higher premiums for automobile insurance, and tobacco smokers often pay higher life insurance premiums. This discrimination, most would agree, is fair and just. However, we as a society have decided that some risk variables should not be . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?